# Collaborations Pharmaceuticals, Inc.

Canonical: https://abierto.us/vendors/collaborations-pharmaceuticals-inc-efjcll37kkh3

- UEI: EFJCLL37KKH3
- CAGE: 7BGW7
- Location: Fuquay Varina, NC
- Awards in window: 1 (1 transactions), $0 obligated, June 24, 2026 to June 24, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N93025C00039 (definitive contract): $0, National Institutes of Health Niaid. Is to Develop Pan-Influenza Inhibitors Targeting the PA Endonuclease from the Viral Replication Complex by Demonstrating Pyronaridine as a Viable Single Dose Treatment for Ebola Infection in NON-HUMAN Primates to Justify Further in Vivo Studies for U. https://www.usaspending.gov/award/CONT_AWD_75N93025C00039_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/collaborations-pharmaceuticals-inc-efjcll37kkh3.